Longevity LifehacksEvidence Map
Interventions/L-Serine
Amino acid · also: serine, D-serine

L-Serine

Amino acid made via brain glycolysis; needed for NMDA receptor signaling and declines in the aging brain.

Summary

Debbie explains that serine is a non-essential amino acid made from glycine or glycolysis, and that astrocytes convert L-serine to D-serine, which is needed alongside glutamate to activate NMDA receptors for learning and memory. She highlights a mouse study showing that reduced brain glycolysis in Alzheimer's-prone mice lowers serine, and that serine in drinking water restored synaptic plasticity and spatial memory. In humans, L-serine was one of four 'combined metabolic activators' in a placebo-controlled Alzheimer's trial that improved cognitive scores, and a single dose improved executive function and spatial memory in healthy older adults. She concludes low serine isn't the whole problem in neurodegeneration but plays a bigger role than she had thought.

Debbie's take
Low serine "isn't the whole problem in neurodegenerative diseases, but it plays a more important role than I had thought." From Serine for Cognitive Enhancement

The evidence

  • Human trial

    In a placebo-controlled randomized trial of 69 Alzheimer's patients, a combination of L-serine, nicotinamide riboside, NAC, and L-carnitine significantly improved ADAS-Cog scores at day 84, with more improvement in those with more severe symptoms (serine's individual effect not isolated).

  • Human trial

    In a clinical trial in healthy older adults in Brazil (average age 73), a 30 mg/kg dose of serine taken 1.5 hours before testing improved executive function and spatial memory.

  • Human trial

    A meta-analysis of schizophrenia trials found D-serine levels are lower and that adding serine to antipsychotic treatment helped symptoms.

  • Animal

    In Alzheimer's-prone mice, reduced glycolysis in astrocytes lowered brain serine by middle age, and serine added to drinking water rescued synaptic plasticity and restored spatial memory.

  • Animal

    In Alzheimer's and Parkinson's animal models, two combined metabolic activator stacks containing L-serine markedly enhanced metabolic and behavioral outcomes.

  • Animal

    In animals, D-serine supplementation reversed age-related declines in brain function.

Doses used in studies

Amounts reported in the research, not dosing recommendations.

DoseContext
12.35 g L-serine (once daily for 28 days, then twice daily)Combined metabolic activator stack in Alzheimer's phase II trial
30 mg/kg single dose, 1.5 hours before testingHealthy older adults (average age 73) in Brazil
12 g/dayTrial in healthy adults with no observable adverse effects
up to 25 g/dayUpper range used in clinical trials
3.5–8 g/dayTypical dietary intake

Cautions

  • Possible bloating or upset stomach at high doses.
  • Supplemental serine may affect mood; talk with a doctor if on medications, especially psychiatric medications, since excess NMDA receptor activation can be harmful.
  • Conversion of L-serine to D-serine requires vitamin B6 as a cofactor; consider whether you could be low in B6.
  • The Alzheimer's trial doses are much higher than usually taken; she does not suggest high doses are needed for prevention at younger ages.

Open questions

Human evidence for serine alone is limited to a single-dose study and schizophrenia trials; the Alzheimer's trial tested a four-supplement combination in existing patients, and she asks at what age serine matters and how to test levels.